Пошук

Illicit drug markets operate through a complex, global chain—from production and trafficking to consumption and the profits that fuel organised crime. At every stage, these activities compromise the health and security of countries...

Since 2003, the Paris Pact Initiative (PPI) has grown into a key international coalition, now comprising 58 partner countries and 22 organisations, including UNODC. It provides a vital platform for consensus-building, linking high-level...

The global market for synthetic drugs has grown rapidly in recent years, with amphetamine-type stimulants (ATS) and new psychoactive substances (NPS) becoming a significant concern worldwide. ATS, which include amphetamine, methamphetamine...

Understanding drug markets in Europe requires monitoring both supply and demand. Traditionally, this has relied on data such as drug seizures, prices, purity and offences. However, because drug markets operate illicitly, gathering and...

The Paris Pact Initiative (PPI), launched in 2003, is one of the leading international coalitions tackling the illicit trafficking of opiates from Afghanistan. Bringing together 58 countries and 23 organisations, including UNODC, it serves...

In 2015, the UNODC-WCO Container Control Programme (CCP) expanded its reach with new Port Control Units (PCUs) across Asia and Europe, including in Bangladesh, Bosnia and Herzegovina, Georgia, Jordan, Nepal, Thailand and Viet Nam, as well...

The rapid rise of synthetic drugs has become one of the world’s most pressing drug-related challenges. After cannabis, amphetamine-type stimulants (ATS) are the most widely used drugs globally, now surpassing cocaine and heroin. Alongside...

The evaluation of Phase III of the Paris Pact Initiative (2010–2012), supported by UNODC’s Project GLO K31, examined how effectively this global partnership has addressed the trafficking and consumption of opiates, particularly those...

The International Narcotics Control Board’s 2015 report on precursors highlights global efforts to stop chemicals being diverted into the illicit manufacture of drugs. It points to successes achieved through international cooperation...

The Council of the European Union is the forum where national ministers from all EU countries come together to make decisions that shape Europe. It is responsible for negotiating and adopting EU laws, approving the budget, concluding...

The EU-CELAC Action Plan 2013–2015 sets out a framework for strengthened cooperation between the European Union and Latin American and Caribbean countries. Building on priorities agreed at the EU-LAC and EU-CELAC Summits, it focuses on key...

The European Union and Central Asian countries have joined forces through the EU–Central Asia Action Plan on Drugs 2014–2020, building on earlier cooperation dating back to 2002. This plan recognises the shared challenges posed by drug...

In 2012, the Council of the European Union adopted the EU Drugs Strategy for 2013–2020, setting a long-term framework to reduce both drug demand and supply. To put this into practice, the Irish Presidency developed the first EU Drugs Action...

The Publications Office of the European Union provides open access to a broad collection of official EU works. Covering everything from policy updates and statistical analyses to educational tools and research findings, the platform gathers...

The Publications Office of the European Union offers free access to a wide range of official EU publications. From research reports and educational resources to policy overviews and statistical studies, the site brings together knowledge...

The EU Drugs Strategy (2013–2020) set out a shared political framework to guide the European Union’s approach to drugs policy. Grounded in the principles of EU law and international conventions, it focused on protecting public health...

his EMCDDA paper explores how better data can help us understand and respond to Europe’s illicit drug markets. Traditional indicators like seizures, prices, purity, and offences provide only part of the picture, so the agency is expanding...

This EMCDDA paper introduces the European Union’s approach to drug supply reduction, explaining how policies, structures, and actions are designed to disrupt drug markets and limit the availability of illicit substances. It highlights the...

This report takes an important step towards understanding how European countries fund efforts to tackle illicit drugs. By examining public spending on supply reduction measures, it highlights how resources are allocated, the gaps in...

In 1999, the EU highlighted the growing threat of drug abuse and trafficking, noting a sharp rise in cocaine, amphetamines, and synthetic drugs like ecstasy. Reports at the time showed that no Member State was spared from these challenges.